MTAA
AV
Market cap403mUSD
Mar 27, Last price
5.00EUR
Name
Antares Vision SpA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Antares Vision S.p.A. specializes in providing sophisticated track & trace and inspection solutions, crucial for ensuring product security and traceability across various industries. Their track and trace portfolio encompasses serialization modules, aggregation systems, comprehensive software suites, verification and decommissioning tools, as well as logistics, warehouse, and bottle tracking technologies. These solutions are vital for sectors such as food, cosmetics, medical devices, pharmaceuticals, and beverages. Beyond traceability, Antares Vision delivers a wide array of inspection solutions. For the beverage sector, these include systems for glass inspection, cap level and bottle orientation control, visual rotation, and print verification. Food manufacturers benefit from contamination detection and container inspection systems. The company also supplies specialized inspection technologies for cosmetics and medical devices. Pharmaceutical clients can leverage advanced machines like tablet and capsule inspectors, parenteral visual rotating inspection systems, raised stopper inspection systems, and LYO-check systems. Furthermore, they offer complete turnkey inspection solutions, notably for beverages derived from their FT system. Complementing its core offerings, Antares Vision provides smart data management tools to facilitate accurate statistics, predictive analysis, and business intelligence. Their service portfolio extends to comprehensive support, including remote and on-site interventions, software maintenance, and remote assistance. They also offer certification training, supply spare parts, and provide expert consulting services. Established in 2007 and based in Travagliato, Italy, Antares Vision S.p.A. operates as a subsidiary of Regolo S.p.A.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||